Tokyo, Jan. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060286) titled 'Retrospective observational study of cross-sectional molecular brain pathology in dementing disease' on Jan. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - dementing disease patients and healthy controls
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to compare and examine the differences of each PET tracer between healthy subjects and dementing disease patients, and to elucidate the pathology of dementing disease.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - about 800 subjects who underwent PET scans (FDG,PiB,DPA713,PK11195,PBB3,FBP/FMM,PM-PBB3,QAA,2FA,CFT,RAC,FMZ,Met,BCPP-EF,BU99008)
Key exclusion criteria - No
Target Size - 800
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 12 Month 04 Day
Date of IRB - 2025 Year 12 Month 04 Day
Anticipated trial start date - 2025 Year 12 Month 04 Day
Last follow-up date - 2030 Year 12 Month 04 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068965
Disclaimer: Curated by HT Syndication.
